Supporting this, previous research has demonstrated that monoclonal antibodies against the C. acnes CAMP factors significantly reduced IL-8 production in inflamed acne tissues, further validating CAMP as a driver of cytokine-mediated inflammation [71]. This evidence concerns the gene CAMP and acne.